Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 1;28(2):284-286.
doi: 10.4103/aian.aian_726_24. Epub 2025 Jan 24.

MOGAD and Mortality: A Rarity

Uk Kandha Kumar  1 , Pradeep K Gunasekaran  2 , Ashna Kumar  1 , Daisy Khera  1 , Sarbesh Tiwari  3 , Lokesh Saini  1
Affiliations

MOGAD and Mortality: A Rarity

Uk Kandha Kumar et al. Ann Indian Acad Neurol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(a-d) Shows bilateral asymmetric T2/FLAIR hyperintensities involving cortical and subcortical areas of bilateral cerebral hemispheres, insula, and head of the caudate nucleus. (e and f) Few of these areas show foci of diffusion restriction. (g and h) (Axial FLAIR and T1 post-contrast) The anterior part of bilateral optic nerves appears edematous and shows mild post-contrast enhancement. FLAIR: fluid-attenuated inversion recovery
Figure 2
Figure 2
(a-d) T2 and FLAIR images showing near-symmetrical gyriform hyperintensities involving bilateral parieto-occipital, frontal, and temporal lobes and insular cortices, bilateral caudate and lentiform nuclei, and bilateral medial thalami. (e and f) Diffusion restriction in bilateral parieto-occipital lobes and bilateral (L > R) claustrum. FLAIR: fluid-attenuated inversion recovery
See this image and copyright information in PMC

References

    1. Brenton JN. Pediatric acquired demyelinating disorders. Continuum (Minneap Minn) 2022;28:1104–30. - PMC - PubMed
    1. Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;22:268–82. - PubMed
    1. Ambrosius W, Michalak S, Kozubski W, Kalinowska A. Myelin oligodendrocyte glycoprotein antibody-associated disease: Current insights into the disease pathophysiology, diagnosis and management. Int J Mol Sci. 2020;22:100. - PMC - PubMed
    1. Sechi E, Cacciaguerra L, Chen JJ, Mariotto S, Fadda G, Dinoto A, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of clinical and MRI features, diagnosis, and management. Front Neurol. 2022;13:885218. - PMC - PubMed
    1. de Mol CL, Wong Y, van Pelt ED, Wokke B, Siepman T, Neuteboom RF, et al. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler. 2020;26:806–14. - PMC - PubMed